Overview

CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
CCRT with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel